Table.
Skin manifestations in COVID-19
| Morphology | Characteristics |
|---|---|
| Maculopapular eruption (47%)* | Perifollicular or PR-like, ± purpura; rarely infiltrated lesions, EM-like or EED-like |
| Urticarial lesions (19%) | Trunk or generalized |
| Pseudo-chilbain (19%) | Acral areas (hands and feet); late in the course of disease |
| Vesiculobullous lesions (9%) | Some with varicella-like features; trunk, limbs; lesions appear commonly before other findings |
| Livedo or necrosis (6%) | Truncal or acral ischemia; lesions suggestive of occlusive vascular disease |
| Other morphologies | Petechiae or purpuric lesions, palmar erythema, perifollicular eruption, pruritus, mucosal lesions |
⁎
A frequency of eruptions as reported by Galván Casa et al.16
COVID-19, coronavirus disease 2019; EED, erythema elevatum diutinum; EM, erythema multiforme; PR, pityriasis rosea.